Revolutionizing Treatment: The Promise of Targeted Therapies in Modern Medicine

Perez Sank

doi:10.4172/2167-065X.1000352

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentry
Clin Pharmacol Biopharm 2023, Vol 12(7): 352
DOI: 10.4172/2167-065X.1000352

Revolutionizing Treatment: The Promise of Targeted Therapies in Modern Medicine

Perez Sank^*: Department of Psychiatry, Albert Einstein College of Medicine, Morris Park Avenue, Bronx, USA

^*Corresponding Author : Perez Sank, Department of Psychiatry, Albert Einstein College of Medicine, Morris Park Avenue, Bronx, USA, Email: perezsank.89@gmail.com

Received Date: Jul 03, 2023 / Published Date: Jul 28, 2023

View PDF Download PDF

Citation: Sank P (2023) Revolutionizing Treatment: The Promise of Targeted Therapies in Modern Medicine. Clin Pharmacol Biopharm, 12: 352. Doi: 10.4172/2167-065X.1000352

Copyright: © 2023 Sank P. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.